Active Ingredient Ibrutinib

Active Ingredient Details

What is the usage for Ibrutinib?

This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system).

How many products in the NDC database contain Ibrutinib?

The NDC database has 31 products with the active ingredient Ibrutinib. The following table lists all the products that have this active ingredient.

NDC Products with Ibrutinib

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
11014-0163Proprietary Name: IbrutinibCapsuleCatalent Pharma Solutions, LlcACTIVE
11014-0326Proprietary Name: IbrutinibTablet, Film CoatedCatalent Pharma Solutions, LlcACTIVE
11014-0327Proprietary Name: IbrutinibTablet, Film CoatedCatalent Pharma Solutions, LlcACTIVE
11014-0328Proprietary Name: IbrutinibTablet, Film CoatedCatalent Pharma Solutions, LlcACTIVE
11014-0329Proprietary Name: IbrutinibTablet, Film CoatedCatalent Pharma Solutions, LlcACTIVE
11014-0397Proprietary Name: IbrutinibTablet, Film CoatedCatalent Pharma Solutions, LlcACTIVE
11014-0417Proprietary Name: IbrutinibCapsuleCatalent Pharma Solutions, LlcACTIVE
15308-2402Proprietary Name: IbrutinibPowderAarti Pharmalabs LimitedACTIVE
40006-040Proprietary Name: IbrutinibPowderLonza Guangzhou Pharmaceutical Ltd.ACTIVE
54893-0046Proprietary Name: Ibrutinib(amorphous)PowderMsn Laboratories Private LimitedACTIVE
54893-0049Proprietary Name: Ibrutinib (form-a)PowderMsn Laboratories Private LimitedACTIVE
54893-0082Proprietary Name: Ibrutinib (form-c)PowderMsn Laboratories Private LimitedACTIVE
54893-0102Proprietary Name: Ibrutinib (form-m5)PowderMsn Laboratories Private LimitedACTIVE
55111-982Proprietary Name: IbrutinibPowderDr.reddy�s Laboratories LimitedACTIVE
57962-007Proprietary Name: Imbruvica IbrutinibSuspensionOralPharmacyclics LlcACTIVE
57962-014Proprietary Name: Imbruvica IbrutinibTablet, Film CoatedOralPharmacyclics LlcACTIVE
57962-070Proprietary Name: Imbruvica IbrutinibCapsuleOralPharmacyclics LlcACTIVE
57962-140Proprietary Name: Imbruvica IbrutinibCapsuleOralPharmacyclics LlcACTIVE
57962-280Proprietary Name: Imbruvica IbrutinibTablet, Film CoatedOralPharmacyclics LlcACTIVE
57962-420Proprietary Name: Imbruvica IbrutinibTablet, Film CoatedOralPharmacyclics LlcACTIVE
58175-0602Proprietary Name: IbrutinibPowderWavelength Enterprises LtdACTIVE
63415-0531Proprietary Name: Ibrutinib HfccPowderAssia Chemical Industries Ltd. - Teva Tech SiteACTIVE
63850-8089Proprietary Name: IbrutinibPowderNatco Pharma LimitedACTIVE
65129-1377Proprietary Name: IbrutinibPowderScinopharm Taiwan Ltd.ACTIVE
65129-1460Proprietary Name: IbrutinibPowderScinopharm Taiwan Ltd.ACTIVE
65129-1471Proprietary Name: IbrutinibPowderScinopharm Taiwan Ltd.ACTIVE
68554-0109Proprietary Name: IbrutinibPowderHetero Labs LimitedACTIVE
69988-0040Proprietary Name: IbutinibPowderCatalent Micron Technologies, Inc.ACTIVE
71796-053Proprietary Name: IbrutinibPowderDr. Reddy's Laboratories LimitedACTIVE
82920-031Proprietary Name: IbrutinibPowderShilpa Pharma Lifesciences LimitedACTIVE
83137-0004Proprietary Name: IbrutinibPowderShanghai Huilun Jiangsu Pharmaceutical Co., Ltd.ACTIVE
<